Insulin adherence remains a significant challenge with approximately 62 percent of patients discontinuing insulin in the first three months and 82 percent in the first year. To resolve this challenge, Common Sensing and Welkin Health have partnered to develop an innovative new program aimed at improving insulin adherence for people living with diabetes.
A first-of-its-kind initiative, the program will combine insulin dosing data, wirelessly transmitted from Common Sensing’s Gocap™, real-time blood glucose data, and data gleaned from Welkin Health coaches who will work closely to support patients in the context of their daily lives. The ability to monitor patient data and behaviors as they occur will equip care teams with a holistic view of each patient’s diabetes profile, enabling them to significantly impact the outcomes of people managing diabetes like never before.
Common Sensing and Welkin’s novel program serves as a solution to improve insulin adherence which continues to be a significant problem for healthcare delivery. Welkin’s platform captures insulin dosing data from the Gocap™ along with automatically transmitted blood glucose data. The platform’s rules engine identifies triggers, such as a drop in glucose levels or a missed insulin dose, and prompts the CDEs to offer real-time feedback and coaching to the user.
“Adherence challenges continue to be an issue for people managing diabetes, yet, research shows, individuals who receive health coaching are likely to be more consistent and adherent to medication,” says Chase Hensel, CEO and co-founder, Welkin Health. “If a patient stops taking their insulin or misses a dose, there’s a reason for that—we want to understand why. The real-time data that care teams will receive through our program, as well as the ability to react swiftly when prompted, will afford more opportunities to keep patients on track with insulin regimens and we believe, vastly improve insulin adherence and overall health outcomes.”
